Cargando…
Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328926/ https://www.ncbi.nlm.nih.gov/pubmed/37420005 http://dx.doi.org/10.1038/s41598-023-38226-2 |
| _version_ | 1785069911174807552 |
|---|---|
| author | Nadesh, Ragima Menon, Krishnakumar N. Biswas, Lalitha Mony, Ullas Subramania Iyer, K. Vijayaraghavan, Sundeep Nambiar, Ajit Nair, Shantikumar |
| author_facet | Nadesh, Ragima Menon, Krishnakumar N. Biswas, Lalitha Mony, Ullas Subramania Iyer, K. Vijayaraghavan, Sundeep Nambiar, Ajit Nair, Shantikumar |
| author_sort | Nadesh, Ragima |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10328926 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103289262023-07-09 Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer Nadesh, Ragima Menon, Krishnakumar N. Biswas, Lalitha Mony, Ullas Subramania Iyer, K. Vijayaraghavan, Sundeep Nambiar, Ajit Nair, Shantikumar Sci Rep Author Correction Nature Publishing Group UK 2023-07-07 /pmc/articles/PMC10328926/ /pubmed/37420005 http://dx.doi.org/10.1038/s41598-023-38226-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Nadesh, Ragima Menon, Krishnakumar N. Biswas, Lalitha Mony, Ullas Subramania Iyer, K. Vijayaraghavan, Sundeep Nambiar, Ajit Nair, Shantikumar Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title | Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title_full | Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title_fullStr | Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title_full_unstemmed | Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title_short | Author Correction: Adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| title_sort | author correction: adipose derived mesenchymal stem cell secretome formulation as a biotherapeutic to inhibit growth of drug resistant triple negative breast cancer |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328926/ https://www.ncbi.nlm.nih.gov/pubmed/37420005 http://dx.doi.org/10.1038/s41598-023-38226-2 |
| work_keys_str_mv | AT nadeshragima authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT menonkrishnakumarn authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT biswaslalitha authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT monyullas authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT subramaniaiyerk authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT vijayaraghavansundeep authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT nambiarajit authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer AT nairshantikumar authorcorrectionadiposederivedmesenchymalstemcellsecretomeformulationasabiotherapeutictoinhibitgrowthofdrugresistanttriplenegativebreastcancer |